Research progress of reperfusion injury salvage kinase and survivor activating factor enhancement signal pathway in myocardial ischemia reperfusion injury
CSTR:
Author:
Affiliation:

Department of Nutrition, Second Clinical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, China)

Clc Number:

R542.2

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Percutaneous coronary intervention and thrombolytic therapy can significantly benefit and improve the prognosis of myocardial infarction patients, but the following problem of myocardial ischemia reperfusion injury is also prominent. Myocardial ischemia reperfusion injury involves multiple target pathways, and the relationship between different signaling pathways is complex. In recent years, reperfusion injury salvage kinase and survivor activating factor enhancement, two novel survival promoting kinase signaling pathways, have emerged as a new target for the treatment of reperfusion intervention, thus becoming a new breakthrough point in cardiovascular diseases and even other vascular diseases. This article aims to explain the mechanism of the protective effects of these two signaling pathways on myocardial ischemia reperfusion, and provide a new approach for the research and development of new drugs for myocardial infarction.

    Reference
    Related
    Cited by
Get Citation

ZHENG Zong-Mei, ZHU Ming-Ming, SHEN Yu-Jun, SU Ning, LU Fen-Ping, LI Xiang, SHI Hong-Fei. Research progress of reperfusion injury salvage kinase and survivor activating factor enhancement signal pathway in myocardial ischemia reperfusion injury[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(11):1174-1178, 1183.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 20,2017
  • Revised:June 27,2017
  • Online: November 28,2017
Article QR Code